NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/09/2024
Voltar para busca
Dado oficial do USPTO
CELLFORCURE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CELLFORCURE
ST13
US500000079106607Classe
5, 35, 36, 40, 42, 44, 45
Pedido
79106607
Registro
4255776
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
57
Atualização mais recente
20/09/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 36, 40, 42, 44, 45
Data de depósito
12/10/2011
Data de registro
11/12/2012
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/06/2023
Última transação
23/06/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
SALEM-HOWEY, AISHA
Unidade examinadora
M40
Titulares e representantes
Titulares
CELLFORCURE
L. B. (pessoa física)
LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 36Classe 40Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations for the treatment of humans and animals suffering from diseases treated by cell therapy or regenerative medicine products ; sanitary preparations for medical purposes; medical plasters; material for dental fillings and dental impressions; all purpose disinfectants
Classe 35
Retail store services featuring tissues and their by-products and preparations for cell therapy for autologous or allogenic therapy purposes; marketing services; importing and exporting agencies for health productsparticularly of medicines for human purposes including medicines for experimental purposesbiological products for experimental purposespreparations for cell therapy and medicines for innovative therapies
Classe 36
Financial and real estate affairs in every type of financialreal estate or securities-related operation and in all commercial or industrial firms in the field of healthfinancial consultancyfinancial analysiscapital accumulation and investmentreal estate appraisal; real estate brokeragereal estate acquisition services for business assets; real estate brokeragerental of commercial property; real estate brokerageleasing and management for others of commercial property; rentalleasing and management of real estateparticularly of all commercial properties in the nature of facilitiesbusinessesfactories and workshops in the health sector
Classe 40
Cryopreservationfor autologous or allogenic therapy purposesof human tissues and their by-products and preparations for cell therapy; custom manufacturing for othersmanufacturing of pharmaceutical and veterinary preparations for health carefor the treatment of humans and animals suffering from diseases treated by cell therapy or regenerative medicine productsparticularly medicines for human purposes including medicines for experimental purposesbiological products for experimental purposespreparations for cell therapy and medicines for innovative therapies
Classe 42
Research and developmentfor autologous or allogenic therapy purposesfor tissues and their by-products and preparations for cell therapy; research and development of health preparationsparticularly of medicines for human purposes including medicines for experimental purposesbiological products for experimental purposespreparations for cell therapy and medicines for innovative therapies; scientific studies relating to the health sector in the field of cell therapy and regenerative medicine
Classe 44
Advice and assistanceproviding information in the field of cell therapy and regenerative medicine for public laboratories and companiesparticularly those in the medical and health sectors
Classe 45
Legal servicesadvice and assistance for public laboratories and companiesparticularly those in the medical and health sectorson state and federal regulatory compliance requirements; legal serviceslicensing of patented or non-patented goodsprocedures and inventions in the field of health
Publicações
Histórico de despachos e eventos da marca no USPTO.
57 publicações encontradas
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/04/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/03/2024
INPC
INVALIDATION PROCESSED
02/03/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
23/02/2024
C71T
CANCELLED SECTION 71
23/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/07/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
26/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/07/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/12/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/11/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/09/2021
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
12/06/2020
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/05/2020
INPC
INVALIDATION PROCESSED
07/05/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
13/02/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
27/12/2019
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
13/06/2019
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
13/06/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/06/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
10/06/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/12/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
27/03/2015
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/07/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/04/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/03/2013
FIMP
FINAL DISPOSITION PROCESSED
15/03/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/03/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
11/12/2012
GPNX
NOTIFICATION PROCESSED BY IB
16/10/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/09/2012
PUBO
PUBLISHED FOR OPPOSITION
25/09/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/09/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/09/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/09/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
23/08/2012
ALIE
ASSIGNED TO LIE
22/08/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/08/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
14/08/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/08/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
14/08/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/08/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/07/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/07/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/07/2012
RFNP
REFUSAL PROCESSED BY IB
06/03/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/02/2012
RFRR
REFUSAL PROCESSED BY MPU
09/02/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2012
CNRT
NON-FINAL ACTION WRITTEN
07/02/2012
DOCK
ASSIGNED TO EXAMINER
31/01/2012
MAFR
APPLICATION FILING RECEIPT MAILED
03/01/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/12/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/12/2011
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLFORCURE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.